What is HYQVIA?

Whether you're still considering your options, switching to subcutaneous immune globulin (subQ Ig) treatment, or already using HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase], this section can help you become more informed about HYQVIA, the only once-a-month subQ Ig for adults with PI.1

HYQVIA is a Once-a-Month SubQ Ig1

HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] needle, infusion site, infusion frequency
A second site can be used at the discretion of the physician and patient based on tolerability and total volume1

With HYQVIA, you have the option to infuse using 1 needle, 1 infusion site, 1 time a month, in the comfort of your own home. If you would feel more comfortable, HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] can also be administered by a healthcare professional at your doctor's office, clinic, or hospital.

See what makes HYQVIA different from other subQ Ig treatments.

More Free Time

Infusing 1 time a month with HYQVIA doesn't mean your infusions will take longer. Typically, infusions take less than 3 hours with HYQVIA.1 Instead, you'll have more free time.

Median time of individual infusions

Help Your Body Fight Off Infections1

Just 1 HYQVIA infusion a month can help your body fight off bacterial and viral infections. As demonstrated in the clinical trial, once-a-month HYQVIA helped reduce the risk of serious infections.

0.025 rate of acute serious bacterial infections during HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] efficacy trial Days in the hospital due to infection during HYQVIA Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] efficacy trial

Maintain Even Levels of Ig1

Immune Globulin Level Chart

HYQVIA helps maintain even levels of Ig in your body.* The peak to trough variation with HYQVIA is similar to conventional subQ administration, even with once-a-month administration. Also, HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] does not have the high peak Ig level experienced with intravenous administration.

*Comparison of mean Ig values for HYQVIA vs IGIV 10% and Conventional SubQ 10%. IGIV 10% and HYQVIA data at 28 day dosing interval; Conventional SubQ 10% data at 7 day dosing interval; Conventional SubQ 10% dotted line shows weekly dose extrapolated over 21 additional days.

What Makes HYQVIA Different?1,2

Conventional subQ Ig treatments require multiple infusions a month, with multiple needles, to receive your monthly dose.

Once a month HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] needle and multiple needles with conventional subQ Ig treatments

HYQVIA is the only once-a-month subQ Ig with Recombinant Human Hyaluronidase (hy•lah•RON•ah•dase) and Ig. The Recombinant Human Hyaluronidase, temporarily opens the subQ space, allowing a larger amount of Ig to reach the subQ tissue and be absorbed into the bloodstream to help fight infection.

It's the reason you can infuse your monthly dose of HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] using 1 needle, 1 infusion site, 1 time a month. A second site can be used at the discretion of the physician and patient based on tolerability and total volume.

HYQVIA is supplied

as a dual-vial unit and is infused sequentially through 1 needle set: 1. Recombinant Human Hyaluronidase (HY) and 2. Human Immune Globulin Infusion 10% (IG).

HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] is supplied as a dual-vial unit with HY and IG


Please expand for Indication and Important Safety Information.

Selected Important Safety Information about HYQVIA
  • HYQVIA can cause blood clots. Call your healthcare professional if you have pain, swelling, warmth, redness, or a lump in your legs or arms, other than at the infusion site(s), unexplained shortness of breath, chest pain or discomfort that worsens on deep breathing, unexplained rapid pulse, numbness or weakness on one side of the body.
  • Do not take HYQVIA if you are allergic to IgG, hyaluronidase, other blood products, human albumin (in the hyaluronidase solution), or have IgA deficiency with antibodies to IgA.
Indication and Important Safety Information
HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Solution
  • HYQVIA is a liquid medicine containing immune globulin and Recombinant Human Hyaluronidase. HYQVIA contains IgG antibodies, collected from human plasma donated by healthy people. The antibodies help your body to fight off bacterial and viral infections. The hyaluronidase part of HYQVIA helps more of the immune globulin get absorbed into the body to fight infection.
  • HYQVIA is indicated for the treatment of Primary Immunodeficiency (PI) involving the humoral immune system in adults.
  • Safety and efficacy of chronic use of Recombinant Human Hyaluronidase in HYQVIA have not been established in conditions other than PI.
  • HYQVIA is infused under the skin (subcutaneous).
  • If you and your healthcare professional decide that home self-infusion of HYQVIA is right for you, then be sure you get instructions and training from your healthcare professional before using HYQVIA at home.
Important Safety Information
    • HYQVIA can cause blood clots.
    • Call your healthcare professional if you have pain, swelling, warmth, redness, or a lump in your legs or arms, other than at the infusion site(s), unexplained shortness of breath, chest pain or discomfort that worsens on deep breathing, unexplained rapid pulse, numbness or weakness on one side of the body.
    • Your healthcare professional may perform blood tests regularly to check your IgG level.
    • With your consent, your healthcare professional may provide blood samples to Shire plc, to test for antibodies that may form against the hyaluronidase part of HYQVIA.
    • Do not infuse HYQVIA into or around an infected or red swollen area because it can cause infection to spread.
    • Talk to your healthcare professional if you become pregnant. Women who become pregnant during HYQVIA treatment are encouraged to enroll in the HYQVIA Pregnancy Registry by calling Medical Information at 1-866-424-6724.

    Do not take HYQVIA if you:

    • Are allergic to IgG, hyaluronidase, other blood products, or human albumin (in the hyaluronidase solution).
    • Have IgA deficiency with antibodies to IgA.

    HYQVIA can cause serious side effects. Call your healthcare professional or go to your emergency department right away if you get:

    • Hives, swelling in the mouth or throat, itching, trouble breathing, wheezing, fainting or dizziness. These could be signs of a serious allergic reaction.
    • Bad headache with nausea, vomiting, stiff neck, fever, and sensitivity to light. These could be signs of swelling in your brain.
    • Reduced urination, sudden weight gain, or swelling in your legs. These could be signs of a kidney problem.
    • Pain, swelling, warmth, redness, or a lump in your legs or arms, other than at the infusion site(s). These could be signs of a blood clot.
    • Brown or red urine, fast heart rate, yellow skin or eyes. These could be signs of a liver or blood problem.
    • Chest pain or trouble breathing, blue lips or extremities. These could be signs of a lung problem.

    What are the possible or reasonably likely side effects of HYQVIA?

    • After HYQVIA infusion a temporary, soft swelling may occur around the infusion site, which may last 1 to 3 days, due to the volume of fluid infused. Mild or moderate pain, redness, swelling, or itching may occur at the site of infusion and generally go away in a few hours. Local reactions are less likely after the first few infusions.
    • The most common side effects of HYQVIA are headache, fatigue, nausea, fever, and vomiting.
    • Antibodies to the hyaluronidase component of HYQVIA were formed in some patients taking HYQVIA. It is not known if there is any long term effect. In theory, these antibodies could react with your body’s own PH20. PH20 is present in the male reproductive tract. So far, these antibodies have not been associated with increased or new side effects.

    These are not all the possible side effects with HYQVIA. Talk to your healthcare professional about any side effects that bother you or that don’t go away.

    Before starting HYQVIA, tell your healthcare professional if you:

    • Have or had any kidney, liver, or heart problems or history of blood clots because HYQVIA can make these problems worse.
    • Have IgA deficiency or a history of severe allergic reactions to IgG or other blood products.
    • Are pregnant, trying to become pregnant or are breast feeding.

    You are encouraged to report suspected side effects by contacting FDA at 1-800-FDA-1088 or www.fda.gov/medwatch or Shire Drug Safety at 1-800-999-1785.

    The risk information provided here is not comprehensive. To learn more, talk about HYQVIA with your healthcare provider or pharmacist.

    Please see the FDA-approved patient labeling